|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ozols RF, Bundy BN, Greer BE, Fowler JM,
Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM
and Baergen R; Gynecologic Oncology Group: Phase III trial of
carboplatin and paclitaxel compared with cisplatin and paclitaxel
in patients with optimally resected stage III ovarian cancer: A
Gynecologic Oncology Group study. J Clin Oncol. 21:3194–3200. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smith HJ, Straughn JM, Buchsbaum DJ and
Arend RC: Epigenetic therapy for the treatment of epithelial
ovarian cancer: A clinical review. Gynecol Oncol Rep. 20:81–86.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Armstrong DK, Bundy B, Wenzel L, Huang HQ,
Baergen R, Lele S, Copeland LJ, Walker JL and Burger RA;
Gynecologic Oncology Group: Intraperitoneal cisplatin and
paclitaxel in ovarian cancer. N Engl J Med. 354:34–43. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Costa FF, Bischof JM, Vanin EF, Lulla RR,
Wang M, Sredni ST, Rajaram V, Bonaldo Mde F, Wang D, Goldman S, et
al: Identification of microRNAs as potential prognostic markers in
ependymoma. PLoS One. 6:e251142011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gattolliat CH, Thomas L, Ciafre SA,
Meurice G, Le Teuff G, Job B, Richon C, Combaret V, Dessen P,
Valteau-Couanet D, et al: Expression of miR-487b and miR-410
encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.
Br J Cancer. 105:1352–1361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haller F, von Heydebreck A, Zhang JD,
Gunawan B, Langer C, Ramadori G, Wiemann S and Sahin O:
Localization- and mutation-dependent microRNA (miRNA) expression
signatures in gastrointestinal stromal tumours (GISTs), with a
cluster of co-expressed miRNAs located at 14q32.31. J Pathol.
220:71–86. 2010. View Article : Google Scholar
|
|
9
|
Lavon I, Zrihan D, Granit A, Einstein O,
Fainstein N, Cohen MA, Cohen MA, Zelikovitch B, Shoshan Y, Spektor
S, et al: Gliomas display a microRNA expression profile reminiscent
of neural precursor cells. Neuro Oncol. 12:422–433. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thayanithy V, Sarver AL, Kartha RV, Li L,
Angstadt AY, Breen M, Steer CJ, Modiano JF and Subramanian S:
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
Bone. 50:171–181. 2012. View Article : Google Scholar
|
|
11
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: microRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gong J, Zhang JP, Li B, Zeng C, You K,
Chen MX, Yuan Y and Zhuang SM: MicroRNA-125b promotes apoptosis by
regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene.
32:3071–3079. 2013. View Article : Google Scholar
|
|
13
|
Henke JI, Goergen D, Zheng J, Song Y,
Schüttler CG, Fehr C, Jünemann C and Niepmann M: microRNA-122
stimulates translation of hepatitis C virus RNA. EMBO J.
27:3300–3310. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Banelli B, Forlani A, Allemanni G,
Morabito A, Pistillo MP and Romani M: MicroRNA in glioblastoma: An
overview. Int J Genomics. 2017:76390842017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Honardoost M and Rad SMAH: Triangle of
AKT2, miRNA, and tumorigenesis in different cancers. Appl Biochem
Biotechnol. 2017.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Slaby O, Laga R and Sedlacek O:
Therapeutic targeting of non-coding RNAs in cancer. Biochem J.
474:4219–4251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu N, Zhao X, Liu M, Liu H, Yao W, Zhang
Y, Cao S and Lin X: Role of microRNA-26b in glioma development and
its mediated regulation on EphA2. PLoS One. 6:e162642011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuninty PR, Schnittert J, Storm G and
Prakash J: MicroRNA targeting to modulate tumor microenvironment.
Front Oncol. 6:32016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sarikas A, Hartmann T and Pan ZQ: The
cullin protein family. Genome Biol. 12:2202011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jackson S and Xiong Y: CRL4s: The
CUL4-RING E3 ubiquitin ligases. Trends Biochem Sci. 34:562–570.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Zhang Y, Douglas L and Zhou P:
UV-damaged DNA-binding proteins are targets of CUL-4A-mediated
ubiquitination and degradation. J Biol Chem. 276:48175–48182. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gupta A, Yang LX and Chen Lc: Study of the
G2/M cell cycle checkpoint in irradiated mammary epithelial cells
overexpressing Cul-4A gene. Int J Radiat Oncol Biol Phys.
52:822–830. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Birner P, Schoppmann A, Schindl M, Dinhof
C, Jesch B, Berghoff AS and Schoppmann SF: Human homologue for
Caenorhabditis elegans CUL-4 protein overexpression is associated
with malignant potential of epithelial ovarian tumours and poor
outcome in carcinoma. J Clin Pathol. 65:507–511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beckman JD, Chen C, Nguyen J, Thayanithy
V, Subramanian S, Steer CJ and Vercellotti GM: Regulation of heme
oxygenase-1 protein expression by miR-377 in combination with
miR-217. J Biol Chem. 286:3194–3202. 2011. View Article : Google Scholar :
|
|
26
|
Savagner P: The epithelial-mesenchymal
transition (EMT) phenomenon. Ann Oncol. 21(Suppl 7): vii89–vii92.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brun JL, Cortez A, Lesieur B, Uzan S,
Rouzier R and Daraï E: Expression of MMP-2, -7, -9, MT1-MMP and
TIMP-1 and -2 has no prognostic relevance in patients with advanced
epithelial ovarian cancer. Oncol Rep. 27:1049–1057. 2012.
View Article : Google Scholar
|
|
28
|
Malisetty VL, Penugurti V, Panta P, Chitta
SK and Manavathi B: MTA1 expression in human cancers-Clinical and
pharmacological significance. Biomed Pharmacother. 95:956–964.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xue Y, Wong J, Moreno GT, Young MK, Côté J
and Wang W: NURD, a novel complex with both ATP-dependent
chromatin-remodeling and histone deacetylase activities. Mol Cell.
2:851–861. 1998. View Article : Google Scholar
|
|
30
|
Formosa A, Markert EK, Lena AM, Italiano
D, Finazzi-Agro E, Levine AJ, Bernardini S, Garabadgiu AV, Melino G
and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c,
miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p
mapped to the 14q32.31 locus, regulate proliferation, apoptosis,
migration and invasion in metastatic prostate cancer cells.
Oncogene. 33:5173–5182. 2014. View Article : Google Scholar
|
|
31
|
Zehavi L, Schayek H, Jacob-Hirsch J, Sidi
Y, Leibowitz-Amit R and Avni D: miR-377 targets E2F3 and alters the
NF-kB signaling pathway through MAP3K7 in malignant melanoma. Mol
Cancer. 14:682015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sabe H: Cancer early dissemination:
Cancerous epithelial- mesenchymal transdifferentiation and
transforming growth factor β signalling. J Biochem. 149:633–639.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial- mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Taylor MA, Parvani JG and Schiemann WP:
The pathophysiology of epithelial-mesenchymal transition induced by
transforming growth factor-beta in normal and malignant mammary
epithelial cells. J Mammary Gland Biol Neoplasia. 15:169–190. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chapman HA: Epithelial-mesenchymal
interactions in pulmonary fibrosis. Ann Rev Physiol. 73:413–435.
2011. View Article : Google Scholar
|
|
37
|
Zhao Y and Sun Y: Cullin-RING Ligases as
attractive anti-cancer targets. Curr Pharm Des. 19:3215–3225. 2013.
View Article : Google Scholar
|
|
38
|
Jia L and Sun Y: SCF E3 ubiquitin ligases
as anticancer targets. Curr Cancer Drug Targets. 11:347–356. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen LC, Manjeshwar S, Lu Y, Moore D,
Ljung BM, Kuo WL, Dairkee SH, Wernick M, Collins C and Smith HS:
The human homologue for the Caenorhabditis elegans cul-4 gene is
amplified and overexpressed in primary breast cancers. Cancer Res.
58:3677–3683. 1998.PubMed/NCBI
|
|
40
|
Schindl M, Gnant M, Schoppmann SF, Horvat
R and Birner P: Overexpression of the human homologue for
Caenorhabditis elegans cul-4 gene is associated with poor outcome
in node-negative breast cancer. Anticancer Res. 27:949–952.
2007.PubMed/NCBI
|
|
41
|
Toda H, Boku S, Nakagawa S, Inoue T, Kato
A, Takamura N, Song N, Nibuya M, Koyama T and Kusumi I: Maternal
separation enhances conditioned fear and decreases the mRNA levels
of the neurotensin receptor 1 gene with hypermethylation of this
gene in the rat amygdala. PLoS One. 9:e974212014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Moon RT, Bowerman B, Boutros M and
Perrimon N: The promise and perils of Wnt signaling through
beta-catenin. Science. 296:1644–1646. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: Diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang L, Yang X, Yang S and Zhang J: The
Wnt/β-catenin signaling pathway in the adult neurogenesis. Eur J
Neurosci. 33:1–8. 2011. View Article : Google Scholar
|
|
45
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Toledo EM, Colombres M and Inestrosa NC:
Wnt signaling in neuroprotection and stem cell differentiation.
Prog Neurobiol. 86:281–296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu F and Millar SE: Wnt/beta-catenin
signaling in oral tissue development and disease. J Dent Res.
89:318–330. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Michaelidis TM and Lie DC: Wnt signaling
and neural stem cells: Caught in the Wnt web. Cell Tissue Res.
331:193–210. 2008. View Article : Google Scholar
|
|
49
|
Liu J, Wang Z, Tang J, Tang R, Shan X,
Zhang W, Chen Q, Zhou F, Chen K, Huang A, et al: Hepatitis C virus
core protein activates Wnt/β-catenin signaling through multiple
regulation of upstream molecules in the SMMC-7721 cell line. Arch
Virol. 156:1013–1023. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Vallée A, Lecarpentier Y, Guillevin R and
Vallee JN: Thermodynamics in gliomas: Interactions between the
Canonical WNT/Beta-catenin pathway and PPAR Gamma. Front Physiol.
8:3522017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mook OR, Frederiks WM and Van Noorden CJ:
The role of gelatinases in colorectal cancer progression and
metastasis. Biochim Biophys Acta. 1705:69–89. 2004.PubMed/NCBI
|
|
52
|
Zhang Y and Wang XF: Post-transcriptional
regulation of MTA family by microRNAs in the context of cancer.
Cancer Metastasis Rev. 33:1011–1016. 2014. View Article : Google Scholar : PubMed/NCBI
|
